Replies to post #56099 on Anavex Life Sciences Corp (AVXL)

[joshalex5]

My guess he releases tomorrow afternoon. Trap shorts.

[margincall16]

Waaaaay too much.

[bas2020]

As mentioned before... I believe there is a conference embargo rule against releasing specific data prior to the conference (a la CTAD). So it doesn't surprise me that we're not hearing about the 12-wk data prior. I expect it to be presented at the conference.

[Jimmy6969]

That's an interesting view. I like it. You may be right.

[ClosetInvestor]

First, I wouldn't rely on "estimates" of when 12 week data should be done. Many here tried that before the November results and we were way off (on # of patients and for how many weeks). For all we know, the last patients enrolled could've delayed getting started on the extension, and so on and so on. There are many variables that could delay data. Again, investors got hyped up for 12 week data, AVXL played no part in that. Yes, Dr. M stated data would be presented at an upcoming conference but that doesn't mean this one. There is loathing wrong with the trial; we may have just got ahead our ourselves as AVXL investors and need to wait a little longer.